Capital Structure Decisions in Swedish Biotechnology Firms: The Role of Intellectual Capital and Innovation Activities
Biotechnology firms operate in a highly innovative and capital-intensive environment, characterized by high levels of R&D, long product development periods, significant regulations, and high levels of uncertainty. These firms rely heavily on intangible assets, such as intellectual capital and in...
Saved in:
| Main Authors: | Kritthana Kimuam, Björn Berggren, Ida Ayu Agung Faradynawati |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | International Journal of Financial Studies |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-7072/13/1/43 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intellectual Capital and Firm Value: An Investigation of Turkish Manufacturing Companies
by: İlhan Çam, et al.
Published: (2022-04-01) -
Cultural Intelligence and Intellectual Capital: Evidence from External Audit Firms
by: Sohail Momeny, et al.
Published: (2025-01-01) -
Intellectual Capital Statement Model for Counties in Poland
by: Jan Fazlagić, et al.
Published: (2018-08-01) -
The Effect of Intellectual Capital, Firm Size and Capital Structure on Firm Performance, Evidence from Property Companies in Indonesia
by: Dwi Asih Surjandari, et al.
Published: (2019-09-01) -
FROM BRICKS TO BRAINPOWER: THE ROLE OF INTELLECTUAL CAPITAL AND FIRM SIZE
by: An Nurrahmawati, et al.
Published: (2024-09-01)